Evidence map›Paper›PMID 26248231›Full record

ArticlePLoS pathogens2015

Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells.

Neha Dikshit, Pradeep Bist, Shannon N Fenlon, Niyas Kudukkil Pulloor, Christelle En Lin Chua, Marci A Scidmore, Jason A Carlyon, Bor Luen Tang, Swaine L Chen, Bindu Sukumaran

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Rab27 in tick extracellular vesicle biogenesis and infection.bioRxiv : the preprint server for biology · 2023
    Article
  6. ThemBio · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Extraintestinal PathogenicMicrobiology spectrum · 2022
    Article
  11. Modified horseshoe crab peptides target and kill bacteria inside host cells.Cellular and molecular life sciences : CMLS · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Neha DikshitProgram in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore.
Pradeep BistProgram in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore.
Shannon N FenlonInfectious Diseases Group, Genome Institute of Singapore, Singapore; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
Niyas Kudukkil PulloorProgram in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore.
Christelle En Lin ChuaDepartment of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Marci A ScidmoreDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
Jason A CarlyonDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States of America.
Bor Luen TangDepartment of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Swaine L ChenInfectious Diseases Group, Genome Institute of Singapore, Singapore; Department of Medicine, Division of Infectious Diseases, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Bindu SukumaranProgram in Emerging Infectious Diseases, Duke-NUS Graduate Medical School, Singapore.
Duke-NUS Medical School · SGNational University of Singapore · SGCornell University · USGenome Institute of Singapore · SGVirginia Commonwealth University · US

Funding

Center for Clinical and Translational ResearchUL1TR000058 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2012 to 2015
$12.5M
The roles of Anaplasma phagocytophilum surface proteins in infectionR01AI072683 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2007 to 2021
$5.8M
The roles of Anaplasma phagocytophilum surface proteins in infectionR37AI072683 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI Jason A Carlyon · 2022 to 2026
$2.6M
NCATS NIH HHS UL1 TR000058NIAID NIH HHS R01 AI072683NIAID NIH HHS R37 AI072683
6 · The paper itself

Abstract

Recurrent urinary tract infections (UTIs) caused by uropathogenic E. coli (UPEC) are common and morbid infections with limited therapeutic options. Previous studies have demonstrated that persistent intracellular infection of bladder epithelial cells (BEC) by UPEC contributes to recurrent UTI in mouse models of infection. However, the mechanisms employed by UPEC to survive within BEC are incompletely understood. In this study we aimed to understand the role of host vesicular trafficking proteins in the intracellular survival of UPEC. Using a cell culture model of intracellular UPEC infection, we found that the small GTPase Rab35 facilitates UPEC survival in UPEC-containing vacuoles (UCV) within BEC. Rab35 plays a role in endosomal recycling of transferrin receptor (TfR), the key protein responsible for transferrin-mediated cellular iron uptake. UPEC enhance the expression of both Rab35 and TfR and recruit these proteins to the UCV, thereby supplying UPEC with the essential nutrient iron. Accordingly, Rab35 or TfR depleted cells showed significantly lower intracellular iron levels and reduced ability to support UPEC survival. In the absence of Rab35, UPEC are preferentially trafficked to degradative lysosomes and killed. Furthermore, in an in vivo murine model of persistent intracellular infection, Rab35 also colocalizes with intracellular UPEC. We propose a model in which UPEC subverts two different vesicular trafficking pathways (endosomal recycling and degradative lysosomal fusion) by modulating Rab35, thereby simultaneously enhancing iron acquisition and avoiding lysosomal degradation of the UCV within bladder epithelial cells. Our findings reveal a novel survival mechanism of intracellular UPEC and suggest a potential avenue for therapeutic intervention against recurrent UTI.

Indexed as

AcetylcysteineAnimalsCell LineEscherichia coliEscherichia coli InfectionsFemaleFluorescent Antibody TechniqueHost-Parasite InteractionsHumansIronMiceMice, Inbred C57BLMicroscopy, ConfocalPolymerase Chain ReactionProtein Transportrab GTP-Binding ProteinsAcetylcysteineIronRAB35 protein, humanRab35 protein, mouserab GTP-Binding Proteins

Identifiers

PMID26248231
PMCPMC4527590
OpenAlexW1112296701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.